Ječmenica-Lukić, Milica (35801126700)Milica (35801126700)Ječmenica-LukićPekmezović, Tatjana (7003989932)Tatjana (7003989932)PekmezovićPetrović, Igor N. (7004083314)Igor N. (7004083314)PetrovićTomić, Aleksandra (26654535200)Aleksandra (26654535200)TomićSvetel, Marina (6701477867)Marina (6701477867)SvetelKostić, Vladimir S. (57189017751)Vladimir S. (57189017751)Kostić2025-06-122025-06-122018https://doi.org/10.1176/appi.neuropsych.17010012https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042366285&doi=10.1176%2fappi.neuropsych.17010012&partnerID=40&md5=85dffa2ffa4a5da7ebaa9fdb732dfdd0https://remedy.med.bg.ac.rs/handle/123456789/6021The aim of this study was to determine the neuropsychiatric profile in a cohort of progressive supranucelar palsy (PSP) patients and their dynamic changes over a follow-up period of 1 year. A total of 59 patientswere assessed at baseline,while 25 of them were accessible after 1 year of the follow-up. The most common symptomswere apathy and depression,which were also found to be, among other variables, the independent determinants of increased Neuropsychiatric Inventory (NPI) total score. Moreover, apathy deteriorated most profoundly over the follow-up period. The NPI seemed to be a sensitive measure of behavioral changes in PSP. © 2018, American Psychiatric Association. All rights reserved.